Matthias Kluckert
Overview
Explore the profile of Matthias Kluckert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bonberg N, Pesch B, Behrens T, Johnen G, Taeger D, Gawrych K, et al.
BMC Cancer
. 2014 Nov;
14:854.
PMID: 25412927
Background: Chromosomal instability in exfoliated urothelial cells has been associated with the development of bladder cancer. Here, we analyzed the accumulation of copy number variations (CNVs) using fluorescence in situ...
2.
Pesch B, Taeger D, Johnen G, Gawrych K, Bonberg N, Schwentner C, et al.
Int Arch Occup Environ Health
. 2013 Oct;
87(7):715-24.
PMID: 24129706
Purpose: To validate urinary markers for the early detection of bladder cancer (BC) in chemical workers. Methods: UroScreen was conducted as a validation study for tumor markers within the frame...
3.
Bonberg N, Taeger D, Gawrych K, Johnen G, Banek S, Schwentner C, et al.
BJU Int
. 2013 Jan;
112(4):E372-82.
PMID: 23350736
Unlabelled: What's known on the subject? and what does the study add?: UroVysion™ is a multicolour fluorescence in situ hybridisation assay that detects DNA gain at chromosomes 3, 7 and...
4.
Johnen G, Gawrych K, Bontrup H, Pesch B, Taeger D, Banek S, et al.
PLoS One
. 2012 Apr;
7(4):e35363.
PMID: 22530010
Background: Urinary biomarkers have the potential to improve the early detection of bladder cancer. Most of the various known markers, however, have only been evaluated in studies with cross-sectional design....